Heartland Group (HGH) H2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2026 earnings summary
20 Aug, 2026Executive summary
Underlying NPAT rose to NZD 90.4 million from NZD 46.9 million year-over-year, with reported NPAT at NZD 93.2 million; all FY26 objectives were met, including restored margins, improved asset quality, and completion of the NSA program.
NSA realization program concluded with a 94% recovery rate, releasing NZD 32 million (USD 31.7 million) of capital and reducing receivables exposure by NZD 254 million.
Announced proposed merger with TSB to create a NZD 15 billion challenger bank, with a conditional agreement to acquire TSB for NZD 620 million.
Declared FY26 final dividend of NZD 0.035 per share, payout ratio of 73%.
Reverse Mortgages and Rural portfolios delivered strong receivables growth of 16.8% and 10.8%, respectively.
Financial highlights
Net operating income increased to NZD 354.3 million, up NZD 31.5 million year-over-year; group underlying NPAT rose 71.9% to NZD 90.4 million.
Cost to income ratio improved by 155 basis points to 54.6%; OPEX was NZD 196.0 million (underlying NZD 193.5 million).
Impairment expense ratio reduced by 55 basis points to 0.45%.
Receivables grew 9.1% to NZD 7,804 million; equity increased 9.7% to NZD 1,337 million.
Underlying EPS rose to 9.6 cps from 5.0 cps.
Outlook and guidance
FY27 NPAT expected to be at least NZD 102 million, excluding merger costs of approximately NZD 9.5 million.
Targeting return on equity of at least 7.5% and reverse mortgage growth above 18% in both countries.
Dividend payout ratio to remain at least 50% of NPAT.
FY27 OPEX expected to be less than NZD 212 million, CTI ratio below 55.7%, impairment expense ratio below 0.32%.
Guidance to be updated upon completion of TSB merger.
Latest events from Heartland Group
- $620M merger forms NZ's seventh largest bank, targeting $34M synergies and EPS growth by 2026.HGH
M&A announcement - Impairment expenses surged amid rising arrears and defaults, with tough conditions expected to continue.HGH
Investor presentation - FY2025 underlying NPAT set to exceed $45m, with strong growth and improved asset quality.HGH
Investor presentation - NPAT surged to $48.8m, with NIM and asset quality gains, and FY2026 guidance reaffirmed.HGH
H1 2026 - Strategic reset, financial rebound, and digital focus drive growth and efficiency.HGH
AGM 2025 - FY2025 underlying NPAT met guidance; FY2026 targets $85m+ NPAT and 7%+ ROE.HGH
H2 2025 - Lower profit but strong receivables growth and strategic transformation set the FY2028 path.HGH
AGM 2024 - Underlying NPAT fell 4.9% below guidance, but strategic growth and digitalisation drive outlook.HGH
H2 2024 - Profit dropped on higher impairments, but reverse mortgage growth and NIM expansion continue.HGH
H1 2025